ACO/ARO/AIO-21 - Capecitabine-based chemoradiotherapy in combination with the IL-1 receptor antagonist anakinra for rectal cancer Patients: A phase I trial of the German rectal cancer study group

PURPOSE: Recent advances in the treatment algorithm of locally advanced rectal cancer (LARC) have significantly improved complete response (CR) rates and disease-free survival (DFS), but therapy resistance, with its substantial impact on outcomes and survival, remains a major challenge. Our group ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Fleischmann, Maximilian, Diefenhardt, Markus, Nicolas, Adele M., Rödel, Franz, Ghadimi, Michael, Hofheinz, Ralf-Dieter, Greten, Florian R., Rödel, Claus, Fokas, Emmanouil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018120/
https://www.ncbi.nlm.nih.gov/pubmed/35449546
http://dx.doi.org/10.1016/j.ctro.2022.04.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9018120/
https://www.ncbi.nlm.nih.gov/pubmed/35449546
http://dx.doi.org/10.1016/j.ctro.2022.04.003

Ejemplares similares